BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule

Reference

• Toivanen P, Toivanen A. Reactive arthritis. Curr Opin Rheumatol 1997;9:321–7.
   PubMedGoogle Scholar
• Stoffel MP, Csemok E, Herzberg C, Johnston TW, Carroll SF, Gross WL. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 1996;104: 54–9.
   PubMed Web of Science ®Google Scholar
• Elsbach P. The bactericidal/permeability increasing in anti-bacterial host defense. J Leukoc Biol 1998;64:14–8.
   PubMed Web of Science ®Google Scholar
• Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. The evolution of spondylarthropathies in relation to gut histology. III Relation between gut and joint. J Rheumatol 1995;22:2279–84.
   Google Scholar
• Dougados M, Van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondy-larthropathy. Arthritis Rheum 1991;34:1218–27.
   PubMed Web of Science ®Google Scholar
• Hagen EC, Andrassy K, Csemok E, Daha MR, Gaskin G, Gross WL, et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection: a report on the first phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods 1993;159:1–16.
   PubMed Web of Science ®Google Scholar
• Schultz H, Csemok E, Johnston TW, Lockwood CM, Gross WL. Use of native and recombinant bactericidal/permeability increasing protein (BPI) as antigens for detection of BPI-ANCA. J Immunol Methods 1997;205:127–33.
   Google Scholar
• Abrahamson SL, Wu HM, Williams RE, Der K, Ottah N, Little R, et al. Biochemical characterisation of recombinant fusions of lipopolysaccharide binding protein and bactericidal/ permeability increasing protein. J Biol Chem 1997;272:2149–55.
   PubMedGoogle Scholar
• Spitznagel JK, Pereira HA, Martin LE, Guzman GS, Shafer WM. A monoclonal antibody that inhibits the antimicrobial action of a 57 kD cationic protein of human polymorph-nuclear leukocytes. J Immunol 1987;139: 1291–6.
   Google Scholar
• Denenter MA, Smit FT, Francot GJM, Buurman WA. Characterization of two monoclonal antibodies directed against bactericidal/permeability increasing protein. J Infect Dis 1994;170:1483–9.
   PubMedGoogle Scholar
• Weinrauch Y, Foreman A, Shu C, Zarember K, Levy O, Elsbach P, et al. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and piss in an evolving sterile rabbit peritoneal inflammatory exsudate. J Clin Invest 1995;95:1916–24.
   Google Scholar
• Locht H, Skogh T, Kihlström E. Anti - lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis. Clin Exp Immunol 1999;117:568–73.
   Google Scholar
• Stoffel MP, Csemok E, Gross WL. Are antineutrophil cytoplasmic antibodies of immunodiagnostic value in reactive arthritis? J Rheumatol 1996;23:1670–2.
   Google Scholar
• Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, et al. Inflammatory bowel disease is associated with increased mucosal levels of Bactericidal/ permeability increasing protein. Gastroenterology 1996;110: 733–9.
   PubMed Web of Science ®Google Scholar
• Iovine NM, Elsbach P, Weiss J. An opsonic function of the neutrophil bactericidal/permeability increasing protein depends on both its N- and C-terminal domains. Proc Natl Acad Sci USA 1997;94:10973–8.
   Google Scholar
• Mahadeva R, Dunn AC, Westerbeek RC, Sharples L, Whitehouse DB, Carroll NR, et al. Anti-neutrophil cytoplas-mic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol 1999;117:561–7.
   PubMed Web of Science ®Google Scholar
• Sadlack B, Merz H, Schorle H, Schimpl A, Feller A, Horak I. Ulcerative colitis - like disease in mice with a disrupted interleukin - 2 gene. Cell 1993;75:253–61.
   PubMed Web of Science ®Google Scholar
• Seibold F, Brandwein S, Simpson S, Terhorst C, Elson CO. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol 1998;18:153–60.
   Google Scholar